Article metrics

Download PDFPDF
Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial

 

Online download statistics by month:

Online download statistics by month: November 2019 to June 2024

AbstractFullPdf
Nov 20194602
Dec 20192701
Jan 20205701
Feb 202020708
Mar 202016507
Apr 20204801
May 202010200
Jun 20208501
Jul 20205600
Aug 20203900
Sep 20203401
Oct 202014600
Nov 202010602
Dec 20205502
Jan 20213400
Feb 20212000
Mar 20211300
Apr 20213801
May 2021600
Sep 2021100
Oct 20211400
Nov 20211900
Dec 20211200
Jan 2022400
Feb 20222400
Mar 20224202
Apr 2022202
May 20221400
Jun 20221800
Jul 20221501
Aug 20225000
Sep 20224801
Oct 20222200
Nov 20222400
Dec 20221600
Jan 20233600
Feb 20231400
Mar 20231900
Apr 20231701
May 20231700
Jun 2023800
Jul 2023600
Aug 2023800
Sep 20231400
Oct 2023400
Nov 20233000
Dec 20232401
Jan 20241801
Feb 20243000
Mar 20241200
Apr 20241200
May 2024900
Jun 20242000
Total1907036